NYSE:CNCHealthcare
Centene (CNC) Stock Looks Below Fair Value While Its 123% Gain Tests Upside
Centene stock has delivered a strong 1 year return while the current valuation checks still point to the shares screening as undervalued on several metrics. This raises the question of how much of that gain is already reflected in the current US$63.41 price.
Over the last 1 year, Centene is up 123.4%, which puts recent buyers in profit and makes the current valuation more important for anyone considering new capital.
Future growth in membership and medical cost control can support earnings,...